Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cell-Secreted Vesicles: Novel Opportunities in Cancer Diagnosis, Monitoring and Treatment. | Diagnostics (Basel) | 2021 | 34205256 | PubTator, text mining | PubMed |
| Epigenetic Upregulation of MAGE-A Isoforms Promotes Breast Cancer Cell Aggressiveness. | Cancers (Basel) | 2021 | 34202157 | PubTator, text mining | PubMed |
| Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC). | Vaccines (Basel) | 2021 | 34201650 | PubTator, text mining | PubMed |
| Adrenocortical Carcinoma Steroid Profiles: In Silico Pan-Cancer Analysis of TCGA Data Uncovers Immunotherapy Targets for Potential Improved Outcomes. | Front Endocrinol (Lausanne) | 2021 | 34194394 | PubTator, text mining | PubMed |
| T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors. | J Hematol Oncol | 2021 | 34193217 | PubTator, text mining | PubMed |
| A Pilot Study of Home-Based Exercise and Personalized Nutrition Counseling Intervention in Endometrial Cancer Survivors. | Front Oncol | 2021 | 34178654 | PubTator, text mining | PubMed |
| T-Cell Receptor Mimic Antibodies for Cancer Immunotherapy. | Mol Cancer Ther | 2021 | 34172530 | PubTator, text mining | PubMed |
| Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma. | PLoS Genet | 2021 | 34166362 | PubTator, text mining | PubMed |
| Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens. | Front Immunol | 2021 | 34149689 | PubTator, text mining | PubMed |
| Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs). | Adv Drug Deliv Rev | 2021 | 34144087 | PubTator, text mining | PubMed |
| Cell Therapy With TILs: Training and Taming T Cells to Fight Cancer. | Front Immunol | 2021 | 34140957 | PubTator, text mining | PubMed |
| Cost-effective purification process development for chimeric hepatitis B core (HBc) virus-like particles assisted by molecular dynamic simulation. | Eng Life Sci | 2021 | 34140854 | PubTator, text mining | PubMed |
| Mutant p53s and chromosome 19 microRNA cluster overexpression regulate cancer testis antigen expression and cellular transformation in hepatocellular carcinoma. | Sci Rep | 2021 | 34135394 | PubTator, text mining | PubMed |
| Immersion in the search for effective cancer immunotherapies. | Mol Med | 2021 | 34134616 | PubTator, text mining | PubMed |
| Toll-Like Receptor-Based Strategies for Cancer Immunotherapy. | J Immunol Res | 2021 | 34124272 | PubTator, text mining | PubMed |
| A lymphodepleted non-human primate model for the assessment of acute on-target and off-tumor toxicity of human chimeric antigen receptor-T cells. | Clin Transl Immunology | 2021 | 34123382 | PubTator, text mining | PubMed |
| AutoEncoder-Based Computational Framework for Tumor Microenvironment Decomposition and Biomarker Identification in Metastatic Melanoma. | Front Genet | 2021 | 34122516 | PubTator, text mining | PubMed |
| Prognostic Alternative Splicing Signatures in Esophageal Carcinoma. | Cancer Manag Res | 2021 | 34113176 | PubTator, text mining | PubMed |
| Advances in multimodal treatment for stage IIIA-N2 non-small cell lung cancer. | J Clin Transl Res | 2021 | 34104821 | PubTator, text mining | PubMed |
| Immunotherapy in non-small cell lung cancer: Update and new insights. | J Clin Transl Res | 2021 | 34104805 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=42